Not much in it , is it worth taking them up ? If the underwriter is saddled with a heap they will flick them on ? Maybe back to the lows after the 20th ?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential